ExploreWatchlistsPricing
  1. US-listed companies
  2. FATE THERAPEUTICS INC
  3. Financials
  4. Property, plant and equipment, net

FATE THERAPEUTICS INC (FATE)

Market cap
$135.27M
P/E ratio
SummaryFinancials
Period EndProperty, plant and equipment, net (Million USD)YoY (%)
Dec 31, 202464-33.51%
Dec 31, 202397-11.98%
Dec 31, 2022110+20.20%
Dec 31, 202192+183.30%
Dec 31, 202032+182.93%
Dec 31, 201911+122.81%
Dec 31, 20185+100.98%
Dec 31, 20173+61.49%
Dec 31, 20162-26.90%
Dec 31, 20152+80.00%
Dec 31, 20141+48.15%
Dec 31, 20131

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat